After Failed Trials, Johnson & Johnson Turns to Early Stage Alzheimer's

Feb 13, 2013 | Posted by: roboblogger | Full story: BioSpace

A little over a year ago, Dr. Husseini Manji, global head of neuroscience drug development at Johnson & Johnson, predicted that brain researchers were on the cusp of a golden age.

Comments

Showing posts 1 - 3 of3
Mikehawkslarge

Santee, CA

|
Report Abuse
|
Judge it!
|
#1
Feb 13, 2013
 
These drugs to remove or prevent plaques will always fail. Not only that, but the bapineuzumab and other antibody meds will increase the cause (Inflamation of the brain) and make things worse. The plaque is not the cause, the inflamation is. Chronic Inflamation results in brain cells responding by making plaques in an attempt to wall off injury and this results in worsening disease. So to be successful you must stop the inflamation OR identify and remove all excitotoxins from our food supply. Substances which are chronically ingested within our food supply are ramping up excitotoxicity. A vaccine is likely to result in an inflamatory response and accelerate the onset.
The phamaceutical industry must learn to treat the actual problem rather than attemting to reduce symptoms. Unfortunately eliminating the problem does not make them the kind of money they get by making people addicts to medications. That is the biggest problem in healthcare, and money will always trump health and wellbeing.
Mikehawkslarge

Santee, CA

|
Report Abuse
|
Judge it!
|
#2
Feb 13, 2013
 
Sorry, in my haste, my previous post had a few typos...I really hate that so here it is corrected:
These drugs to remove or prevent plaques will always fail. Not only that, but the bapineuzumab and other antibody meds will increase the cause (Inflammation of the brain) and make things worse. The plaque is not the cause, the inflammation is. Chronic Inflammation results in brain cells responding by making plaques in an attempt to wall off injury and this results in worsening disease. So to be successful you must stop the inflammation OR identify and remove all excitotoxins from our food supply. Substances which are chronically ingested within our food supply are ramping up excitotoxicity. A vaccine is likely to result in an inflammatory response and accelerate the onset.
The pharmaceutical industry must learn to treat the actual problem rather than attempting to reduce symptoms. Unfortunately eliminating the problem does not make them the kind of money they get by making people addicts to medications. That is the biggest problem in healthcare, and money will always trump health and wellbeing.
Elyza

Kansas City, MO

|
Report Abuse
|
Judge it!
|
#3
Feb 22, 2013
 
Mikehawkslarge wrote:
Sorry, in my haste, my previous post had a few typos...I really hate that so here it is corrected:
These drugs to remove or prevent plaques will always fail. Not only that, but the bapineuzumab and other antibody meds will increase the cause (Inflammation of the brain) and make things worse. The plaque is not the cause, the inflammation is. Chronic Inflammation results in brain cells responding by making plaques in an attempt to wall off injury and this results in worsening disease. So to be successful you must stop the inflammation OR identify and remove all excitotoxins from our food supply. Substances which are chronically ingested within our food supply are ramping up excitotoxicity. A vaccine is likely to result in an inflammatory response and accelerate the onset.
The pharmaceutical industry must learn to treat the actual problem rather than attempting to reduce symptoms. Unfortunately eliminating the problem does not make them the kind of money they get by making people addicts to medications. That is the biggest problem in healthcare, and money will always trump health and wellbeing.
@ Mikehawkslarge, I have to agree with you. It makes you wonder if drug companies ever cared about what is best for consumers/patients or what is best for their numbers. As I was scouring the net, I also came across this article at http://news.yahoo.com/depuy-asr-lawsuit-hip-i... that is related to one of the mishaps by Johnson and Johnson.

Tell me when this thread is updated: (Registration is not required)

Add to my Tracker Send me an email

Showing posts 1 - 3 of3
Type in your comments below
Name
(appears on your post)
Comments
Characters left: 4000
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

10 Users are viewing the Biotech Forum right now

Search the Biotech Forum:
Topic Updated Last By Comments
FDA Approves Weekly Type 2 Diabetes Medicine 12 hr cjuul62 1
US top court denies Israel's Teva Pharmaceutica... Sat Jorja Fox 2
Steering a company in a new direction Apr 15 Philip Cohen 1
GlaxoSmithKline faces bribery investigation in ... Apr 14 Pigs three different ones 3
Effective Messages in Vaccine Promotion: A Rand... Apr 11 CENSORSHIP 2
Lawsuits filed over Lipitor side effects (Jun '06) Apr 9 Marilyn 843
Poor mental health linked to reduced life expec... (Aug '12) Apr 8 Elise Gingrich 5
•••
•••
•••
•••